PISCIANZ, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 5.888
EU - Europa 3.972
AS - Asia 2.249
SA - Sud America 248
AF - Africa 69
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.442
Nazione #
US - Stati Uniti d'America 5.798
PL - Polonia 2.106
SG - Singapore 797
CN - Cina 502
IT - Italia 467
SE - Svezia 368
VN - Vietnam 261
HK - Hong Kong 247
BR - Brasile 183
UA - Ucraina 164
FR - Francia 160
DE - Germania 152
GB - Regno Unito 99
BD - Bangladesh 96
FI - Finlandia 83
RU - Federazione Russa 83
TR - Turchia 83
KR - Corea 69
IE - Irlanda 68
NL - Olanda 63
BG - Bulgaria 57
IN - India 54
CA - Canada 37
MX - Messico 27
AR - Argentina 25
BE - Belgio 21
JP - Giappone 21
ES - Italia 19
SN - Senegal 18
MA - Marocco 15
AT - Austria 14
ZA - Sudafrica 11
IQ - Iraq 10
PK - Pakistan 10
SA - Arabia Saudita 10
VE - Venezuela 10
AU - Australia 9
PH - Filippine 9
DK - Danimarca 8
ID - Indonesia 8
IL - Israele 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
TH - Thailandia 7
CL - Cile 6
MY - Malesia 6
CH - Svizzera 5
CR - Costa Rica 5
EC - Ecuador 5
EG - Egitto 5
IR - Iran 5
JO - Giordania 5
LT - Lituania 5
PT - Portogallo 5
RO - Romania 5
CZ - Repubblica Ceca 4
EU - Europa 4
HN - Honduras 4
PY - Paraguay 4
TW - Taiwan 4
UZ - Uzbekistan 4
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
DZ - Algeria 3
NG - Nigeria 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
PE - Perù 3
PR - Porto Rico 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AO - Angola 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GE - Georgia 2
HU - Ungheria 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
NI - Nicaragua 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
TM - Turkmenistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
EE - Estonia 1
FJ - Figi 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 12.435
Città #
Warsaw 2.055
Ashburn 591
Fairfield 587
Woodbridge 534
Singapore 488
Houston 436
Chandler 323
Ann Arbor 309
Seattle 265
San Jose 263
Wilmington 259
Hong Kong 241
Jacksonville 167
Cambridge 159
Beijing 128
Chicago 124
Los Angeles 123
Trieste 115
Princeton 94
Boardman 92
Ho Chi Minh City 71
Columbus 64
Seoul 61
Izmir 57
Sofia 57
Dallas 54
Dublin 54
Dearborn 51
Hanoi 49
New York 46
Santa Clara 46
Lauterbourg 45
Council Bluffs 42
Zgierz 41
Frankfurt am Main 39
Moscow 38
Salt Lake City 38
Buffalo 36
Dong Ket 36
Hefei 32
Milan 31
Munich 30
Rome 27
San Diego 27
The Dalles 27
Helsinki 25
Düsseldorf 23
Elk Grove Village 23
London 21
Orem 21
São Paulo 21
Tampa 21
Brussels 19
Phoenix 19
Dakar 18
Jinan 18
Nanjing 16
Brooklyn 14
Da Nang 14
Des Moines 13
Falls Church 13
Montreal 13
Shannon 13
Casablanca 12
Guangzhou 12
Haiphong 12
Kunming 12
Stockholm 12
Tokyo 12
Denver 11
Portsmouth 11
Shanghai 11
Atlanta 10
Chennai 10
Mumbai 10
Nuremberg 10
Poplar 10
Redondo Beach 10
Redwood City 10
Turku 10
Amsterdam 9
Bremen 9
Kocaeli 9
San Francisco 9
Washington 9
Hebei 8
Johannesburg 8
Manchester 8
Mexico City 8
Ottawa 8
Sydney 8
Tianjin 8
Vienna 8
Bexley 7
Boston 7
Catania 7
Grafing 7
Hangzhou 7
Lancaster 7
Sterling 7
Totale 9.120
Nome #
The complex interplay between lipids, immune system and interleukins in cardio-metabolic diseases 629
Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response 485
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 454
Neuronal Dysfunction Associated with Cholesterol Deregulation. 435
Curcumin anti-apoptotic action in a model of intestinal epithelial inflammatory damage 415
To extinguish the fire from outside the cell or to shutdown the gas valve inside? Novel trends in anti-inflammatory therapies 412
Type i interferon-mediated autoinflammation due to DNase II deficiency 404
Altered pattern of tumor necrosis factor-Alpha production in peripheral blood monocytes from Crohn's disease basic study 395
Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway. 393
Knockdown of MVK does not lead to changes in NALP3 expression or activation 369
Reappraisal of Antimalarials in Interferonopathies: New Perspectives for Old Drugs 354
Clinical Genetic Testing of Periodic Fever Syndromes 310
An Easy and Reliable Strategy for Making Type I Interferon Signature Analysis Comparable among Research Centers 307
Impact of methylmercury and other heavy metals exposure on neurocognitive function in children of 7 years old: study protocol of the follow-up 299
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response 292
Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes 288
Fate of Lymphocytes after Withdrawal of Tofacitinib Treatment 285
Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype 281
Piccolipiù, a multicenter birth cohort in Italy: protocol of the study. 277
Is autophagy an elective strategy to protect neurons from dysregulated cholesterol metabolism? 276
In vivo detection of polyomaviruses JCV and SV40 in mesenchymal stem cells from human umbilical cords 273
Differential action of 3-hydroxyanthranilic acid on viability and activation of stimulated lymphocytes. 264
Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes. 263
The immunosuppressive effect of Wharton's jelly stromal cells depends on the timing of their licensing and on lymphocyte activation 250
Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency 243
Inhibition of mesenchymal stromal cells by pre-activated lymphocytes and their culture media. 238
Regulatory T-Cell Function Is Impaired in Celiac Disease. 235
Putative modifier genes in mevalonate kinase deficiency 216
Selective resistance to different glucocorticoids in severe autoimmune disorders 207
From Bone Marrow Transplantation to Cellular Therapies: Possible Therapeutic Strategies in Managing Autoimmune Disorders 194
Clinical and Cytometric Study of Immune Involvement in a Heterogeneous Cohort of Subjects With RASopathies and mTORopathies 193
Corrigendum to “Tregs and Th17 lymphocytes in human DYRK1A haploinsufficiency” [Immunol. Lett. 214 (2019) 52–54](S0165247819302342)(10.1016/j.imlet.2019.08.003) 190
Lovastatin induces apoptosis through the mitochondrial pathway in an undifferentiated SH-SY5Y neuroblastoma cell line 188
Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic 184
Mevalonate kinase deficiency: therapeutic targets, treatments, and outcomes 181
Pulmonary arterial hypertension in interferonophaties: a case report and a review of the literature 181
Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis 174
Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex Vivo Study 164
Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line. 161
Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency 160
Hydroxychloroquine modulates immunological pathways activated by RNA:DNA hybrids in Aicardi–Goutières syndrome patients carrying RNASEH2 mutations 160
Immunity and Genetics at the Revolving Doors of Diagnostics in Primary Immunodeficiencies 159
Priming of the cgas‐sting‐tbk1 pathway enhances lps‐induced release of type i interferons 150
New Mechanisms in Autoinflammatory Diseases 149
Familial hypogammaglobulinemia with high RTE and naïve T lymphocytes 131
The effect of clodronate on a mevalonate kinase deficiency cellular model. 123
Tregs and Th17 lymphocytes in human DYRK1A haploinsufficiency 110
null 109
null 108
Totale 12.718
Categoria #
all - tutte 31.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.416


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202185 0 0 0 0 0 0 0 0 0 0 0 85
2021/2022714 37 30 71 60 48 54 35 27 79 64 43 166
2022/20231.001 114 158 71 133 89 141 6 95 123 16 39 16
2023/2024596 24 46 47 29 55 59 122 106 5 9 43 51
2024/20251.307 22 51 106 136 124 90 96 86 172 171 130 123
2025/20263.320 617 105 198 197 273 240 508 98 376 392 166 150
Totale 12.718